Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Aditxt, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 13 | 11 | −2 |
| Shares | 286.2K | 76.6K | −209.6K (−73.2%) |
| Value | $29.7K | $13.9K | −$15.8K (−53.3%) |
New holders (3)
Institutions that held Aditxt, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 11,354 | $2.15K | 0.00% |
| SBI Securities Co., Ltd. | 2,001 | $380 | 0.00% |
| Jones Financial Companies LLLP | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Aditxt, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Two Sigma Investments, LP | 32,042 | $3.44K |
| Jane Street Group, LLC | 30,613 | $3.28K |
| StoneX Group Inc. | 19,423 | $2.08K |
| Geode Capital Management, LLC | 17,697 | $1.90K |
| Morgan Stanley | 37 | $4 |